Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PANTOPRAZOLE Cause Prothrombin time prolonged? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Prothrombin time prolonged have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.0% of all adverse event reports for PANTOPRAZOLE.

17
Reports of Prothrombin time prolonged with PANTOPRAZOLE
0.0%
of all PANTOPRAZOLE reports
2
Deaths
10
Hospitalizations

How Dangerous Is Prothrombin time prolonged From PANTOPRAZOLE?

Of the 17 reports, 2 (11.8%) resulted in death, 10 (58.8%) required hospitalization, and 1 (5.9%) were considered life-threatening.

Is Prothrombin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does PANTOPRAZOLE Cause?

Chronic kidney disease (28,127) Acute kidney injury (15,961) Renal failure (11,543) End stage renal disease (8,523) Renal injury (7,070) Drug ineffective (5,487) Off label use (4,279) Pain (4,057) Dyspnoea (4,052) Fatigue (3,797)

What Other Drugs Cause Prothrombin time prolonged?

WARFARIN (257) RIVAROXABAN (253) ACETAMINOPHEN (201) ASPIRIN (102) DABIGATRAN ETEXILATE (84) APIXABAN (82) ENOXAPARIN (52) IBUPROFEN (49) METHOTREXATE (49) AMIODARONE (44)

Which PANTOPRAZOLE Alternatives Have Lower Prothrombin time prolonged Risk?

PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS PANTOPRAZOLE vs PANTOTHENIC ACID PANTOPRAZOLE vs PAPAVERINE PANTOPRAZOLE vs PARACETAMOL PANTOPRAZOLE vs PARATHYROID HORMONE

Related Pages

PANTOPRAZOLE Full Profile All Prothrombin time prolonged Reports All Drugs Causing Prothrombin time prolonged PANTOPRAZOLE Demographics